Document:

EXHIBIT 10.6

                              EMPLOYMENT AGREEMENT

         THIS AGREEMENT ("Agreement") is made by and between SAMARITAN
PHARMACEUTICALS, INC. a Nevada Corporation ("Company") and Thomas Lang, an
individual ("Executive"), as of June 1, 2004 (the "Effective Date"), who agree
as follows:

1. Recitals. This Agreement is made with reference to the following material
facts:

         1.1      Executive is presently employed by Company pursuant to an oral
agreement.

         1.2 The parties desire to continue Executive's employment with the
Company pursuant to the written agreement set forth herein.

2. Employment.

         2.1 Company hereby engages and employs Executive in the capacity of
Chief Drug Development Officer, as of the Effective Date (the "Employment"). The
Company's Board of Directors (the "Board") may also provide such additional
designations of title to Executive as the Board, in its discretion, may deem
appropriate. Executive agrees to perform the executive duties and functions
customarily associated with the offices of Chief Drug Development Officer and as
specified from time to time by the Board.

         2.2 Except for legal holidays, vacations and absences due to temporary
illness or as otherwise permitted pursuant to company policy, Executive shall
devote a majority of his time, attention and energies to the business of the
Company. Executive represents and warrants to the Company that he is under no
restriction, limitation or other prohibition to perform his duties as described
herein.

3. Term. The term of this Agreement (the "Term"), shall commence on the
Effective Date hereof and shall continue for a period of four (4) years
thereafter unless terminated earlier as provided hereinafter.

4. Compensation.

         4.1. Base Salary. Executive's initial salary shall be $300,000 per
annum. This salary level will be reviewed at least annually by the Board, but
will not be reduced without Executive's prior written consent. This annual
salary of $300,000 shall be payable in equal by-weekly installments before
deductions for employment taxes and other deductions mandated by law. The amount
of unpaid salary may be paid upon determination of the Employer or the Employee
at any time, in stock or converted to shares of Common Stock of the Company. The
amount of stock issued shall equal to the amount due divided by the lowest close
price of the stock quoted on the exchange or medium where the stock is trading,
for the period for which the salary has been earned divided by (1- Rdiscount)
one minues the current discount rate for restricted stock offered by the
company. Additionally, prior to the end of each year of employment and
commencement of the next year of employment under this Agreement, the parties
agree to mutually set an increase in the then Annual Salary considering such
factors as performance, cash flow, increases to other members of management,
revenues and other considerations.

         4.2      Bonus.

                  a) The Executive shall receive bonus payments in accordance to
the following schedule: $50,000 for FDA approval to move to Phase III or Phase
II/III for HIV drug SP-01A and $50,000 for each Investigational New Drug
Applications "Granted" by the FDA.

                  b) The Executive shall also receive a one time signing bonus
of 100,000 options at $1.00 with an expiration of three years.

                  c) Upon moving, a flat rate of $30,000 for moving expenses for
relocating to Las Vegas.

<PAGE>

         4.3 Stock Options. The Executive shall receive a grant of 1,200,000
  options. One quarter (1/4) of said Stock Options shall vest every year. The
  price of the options shall $1.08 with a term of 10 years. Upon termination of
  Executive, as provided hereinafter, Executive's said 1,200,000 options (vested
  and non-vested) shall expire within 30 days.

         4.4 Retirement Benefits. Company shall provide Executive with the
opportunity to participate in all of Company's qualified defined benefit and
defined contribution retirement plans, subject to the eligibility and
participation requirements of such plans.

         4.5 Vacation. Executive shall receive three (3) weeks paid vacation
each year which shall be taken in accordance with the Company's vacation policy.
Executive shall also receive all the paid holidays observed by the Company, and
any other paid absence days established by Company policy.

         4.6 At-Will Employment. Executive agrees that Executive's employment
and compensation from Company can be terminated, with or without cause, and
without notice, at any time, at the option of either Executive or Company.
Executive understands that no executive or Company representative, other the
Company's Board of Directors, has authority to enter into an agreement for
employment with Company for any specific period of time, or to make any
agreement contrary to the foregoing. Any such agreement must be in writing.

5. Other Covenants of the Parties.

         5.1. Intellectual Property Rights.

                  (a) Executive shall promptly and fully inform Company of, and
disclose to Company, any and all ideas, concepts, themes, inventions, designs,
creations, improvements and discoveries that he makes during the term of this
Agreement, whether individually or jointly in collaboration with others, which
are, at the time any such item is conceived or reduced to practice, related to
Company's business or to actual or demonstrably anticipated research or
development of Company, or which result from any work performed by Executive for
Company.

                  (b) Executive agrees that any and all ideas, concepts, themes,
inventions, designs, creations, improvements or discoveries conceived, developed
or written by Executive either individually, or jointly in collaboration with
others, which are related to Company's business, whether patentable or
unpatentable or copyrightable or uncopyrightable, shall belong to and be the
sole and exclusive property of Company.

                  (c) Executive shall assist Company in obtaining patents or
copyright registration on such intellectual properties an execute all documents
and do all things necessary to enable Company to obtain and enforce full an
exclusive title to such properties which are related to Company's business.

         5.2. Non-Competition. The Employee agrees that he will not, jointly or
collectively as a participant in a partnership, sole proprietorship, corporation
or other entity, or as an operator, investor, shareholder, partner, director,
employee, consultant, manager, advisor or in any other capacity whatsoever,
either directly or indirectly, during the term of this Agreement, do any of the
following:

          (i)     establish or pursue, directly or indirectly, the same or
                  similar business as that of the Employer wherever pursued by
                  Employer; or

         (ii)     directly or indirectly request or advise any past, present or
                  future customers or suppliers of the Employer to withdraw,
                  curtail or cancel any of their business or other
                  relationships.

<PAGE>

Further, he agrees that the restrictions contained herein are reasonable
restraints upon the Employee and any violation of the terms of this Section
could have a substantial detrimental effect on Employer. Employee has carefully
considered the nature and extent of the restrictions imposed hereunder and the
rights and remedies conferred upon Employer under the provisions of this
Section, and hereby acknowledges and agrees that same are reasonable in time and
territory, are designed to eliminate competition which would otherwise be unfair
to Employer, do not stifle the Employee's inherent skill and experience, would
not operate as a bar to the Employee's sole means of support, are fully required
to protect the legitimate interest of Employer and do not confer a benefit upon
Employer disproportionate to the detriment of Employee. Any damages resulting
from violation of any of the covenants contained in this Section will be
difficult to ascertain and for that reason agree that Employer shall be entitled
to an injunction from any court of competent jurisdiction restraining any
violation of any or all of this Section, either directly or indirectly, and such
right to injunction shall be in addition to whatever other remedies Employer may
have.

The parties acknowledge that this Section has been called to the parties'
attention and the parties understand it is a material covenant and that without
this Section this Agreement, and all documents executed pursuant hereto, would
not have been entered into by Employer. It is hereby further recognized and
agreed that this Section, the prevailing party shall be entitled to recover any
and all reasonable attorneys' fees and other costs of litigation, through
appeals; if any provision of this Section is held to be unenforceable, such
enforcement term of immediately lesser effect shall be substituted. Employee has
had access to certain valuable information concerning the Employer including,
without limitation, contracts, business plans, customer, employee and supplies
lists, trade secrets, financial performance and prospects, and therefore agrees
that any and all such information, even though it may have been contributed,
developed or acquired by Employee, will become the exclusive property of
Employer and Employee will not directly or indirectly disclose any such
information, unless necessary and pursuant to this Agreement.

6. General Provisions.

         6.1 Gender. Wherever the context shall require, all words herein in the
masculine gender shall be deemed to include the feminine or neuter gender, all
singular words shall include the plural, and all plural shall include the
singular.

         6.2 No Assignment. Neither party may assign this Agreement without the
prior written consent of the other.

         6.3 Complete Agreement. This Agreement contains the entire agreement of
the parties with respect to the subject matter hereof and supersedes all
previous oral and written agreements and all contemporaneous oral negotiations,
commitments, writings and understandings.

         6.4 Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

         6.5 Governing Law. This Agreement shall be governed by, and construed
in accordance with, the internal laws of the State of Nevada.

         6.6 Modifications and Waivers. No waiver or modification of this
Agreement shall be binding unless it is in a writing signed by both parties
hereto.

         6.7 Severability. In the event any provision or provisions of this
Agreement is or are to be held invalid, the remaining provisions of this
Agreement shall not be affected thereby.

         6.8 Legal Fees. If any legal action, arbitration or other proceeding is
brought for the enforcement of this Agreement, or because of any alleged
dispute, breach or default in connection with this Agreement, the successful or
prevailing party shall be entitled to recover all of its costs incurred in such
action or proceeding, including without limitation its actual attorneys' fees
and disbursements, in addition to any other relief to which it may be entitled.

<PAGE>

         6.9 Notices. All notices and other communications required or permitted
under this Agreement shall be in writing, served personally on, or mailed by
certified or registered United States mail to, the party to be charged with
receipt hereof. Notices and other communications served by mail shall be deemed
given hereunder seventy-two (72) hours after deposit of such notice or
communication in the United States Post Office as certified or registered mail
with postage prepaid and duly addressed to the receiving party as follows, or at
such other address as such party has designated in a written notice given as
provided herein:

    To Company:                                      To Executive:
    Samaritan Pharmaceuticals, Inc                   Thomas Arnold Lang
    101 Convention Center Drive                      101 Convention Center Drive
    Suite 310                                        Suite 310
    Las Vegas, Nevada 89109                          Las Vegas, Nevada 89109

         6.10 Construction. The language of this Agreement shall be construed
simply and according to its fair meaning, and shall not be construed for or
against any party hereto as a result of the source of its draftsmanship.

         6.11 Arbitration. Any controversy or claim arising out of or relating
to this Agreement, or an alleged breach of this Agreement, shall be settled by
arbitration administered by the American Arbitration Association, and judgment
on the award rendered by the arbitrator(s) may be entered in the District Court
in and for Clark County, Nevada. In case of a dispute, any party may commence
arbitration by giving written notice to the others of its desire to do so. Each
party hereto agrees that service of process for an arbitration proceeding will
be deemed completed when a notice of another party's desire to arbitrate is
received by such party. Each party hereby agrees that any such arbitration shall
be held in Las Vegas, Nevada and consents to the jurisdiction of the District
Court in and for Clark County for entering of any judgment. The arbitrator shall
have authority equal to that of a District Court Judge to grant equitable relief
in an action pending in Clark County District Court in which all parties have
appeared. Judgment upon the Arbitrator's award may be entered as if after trial
in accordance with Nevada law. Should any party fail to pay fees as required,
any other party may advance the same and shall be entitled to a judgment from
the arbitrator in the amount of such fees plus interest. Any award issued by the
arbitrator shall bear interest at the judgment rate in effect in the State of
Nevada from the date determined by the arbitrator.

         6.12 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument, even though the parties
do not sign the same counterpart.

IN WITNESS WHEREOF the parties hereto do hereby execute and make effective this
Agreement as of the Effective Date.

COMPANY:                                   EXECUTIVE:

By: /s/ Cynthia Thompson                By: /s/ Thomas Lang
    --------------------                    -----------------
Name: Cynthia Thompson                     Name: Thomas Lang
Title: Independent Director                Title: Chief Drug Development Officer

By: /s/ Welter Holden
    ------------------
Name: Welter Holden
Title: Independent Director

By: /s/ Brian Sullivan
    -------------------
Name: Brian Sullivan
Title: Independent Director

By: /s/ Janet Greeson
    -------------------
Name: Janet Greeson
Title: Chief Executive OfficerSECOND EXCHANGE AGREEMENT

         THIS AGREEMENT made as of this _____ day of June, 2004, by and between
BRITTANY CAPITAL MANAGEMENT LTD., a corporation organized under the laws of the
Bahamas ("Investor"), and HOMECOM COMMUNICATIONS, INC., a Delaware corporation
("HCOM" or the "Company") .

         The following terms shall have the specified definitions, unless the
context otherwise requires:

         "Common Stock" shall mean the common stock of HCOM, $0.0001 par value
per share.

                                 R E C I T A L S

         A. The Investor is the owner of good and marketable title to 5,640,000
shares of the Common Stock of HCOM (the "Securities"), free and clear of all
liens, pledges and encumbrances.

         B. HCOM wishes to acquire the Securities for $0.10 per share.

         C. In consideration of the transfer to HCOM of certain of the
Securities, the Investor will receive, subject to the terms and conditions set
forth herein, the Series ____Convertible Preferred Stock, (the "Preferred
Stock") and being in the form and having the terms and conditions as set forth
in Annex I attached hereto in exchange for the Securities.

         NOW, THEREFORE, for and in consideration of the premises and the mutual
agreement contained herein and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

         1.       On the Closing Date (as defined below), HCOM agrees to
purchase from the Investor 4,165,000 of the Securities.

                                       1

<PAGE>

         2.       In consideration therefore, HCOM agrees to issue to the
Investor, the Preferred Stock.

         3.       MUTUAL DELIVERIES. (a) On the Closing Date the Investor shall
deliver the Securities to HCOM and HCOM shall deliver to the Investor the
Preferred Stock duly endorsed for transfer (the "Exchange").

         4.       CLOSING DATE.  Subject to the satisfaction (or waiver) of the
conditions thereto set forth in Section 9 and Section 10 below, the date and
time of the Exchange pursuant to this Agreement (the "Closing Date") shall be
12:00 noon Eastern Standard Time on June ___, 2004 or such other mutually agreed
upon time. The closing of the transactions contemplated by this Agreement shall
occur on the Closing Date at the offices of Krieger & Prager LLP, 39 Broadway,
Suite 1440, New York, New York or at such other location as may be agreed to by
the parties.

         5.       REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company
represents and warrants to the Investor that:

         (a) The Company has the corporate power and authority to enter into
this Agreement, and to perform its obligations hereunder. The execution and
delivery by the Company of this Agreement and the consummation by the Company of
the transactions contemplated hereby have been duly authorized by all necessary
corporate action on the part of the Company. This Agreement has been duly
executed and delivered by the Company and constitutes valid and binding
obligations of the Company enforceable against it in accordance with its terms,
subject to the effects of any applicable bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors' rights generally and to the
application of equitable principles in any proceeding (legal or equitable).

                                       2

<PAGE>

                  (b) To the actual knowledge of the Company, the execution,
delivery and performance by the Company of this Agreement, and the consummation
of the transactions contemplated hereby, do not and will not breach or
constitute a default under any applicable law or regulation or of any agreement,
judgment, order, decree or other instrument binding on the Company which breach
or default could reasonably by expected to have a material adverse effect on the
Company taken as a whole.

                  (c) Other than as disclosed in the Company's reports or
registration statements as filed with the Securities and Exchange Commission
(the "SEC"), including the exhibits thereto (the "SEC Documents"), there is no
pending, or to the actual knowledge of the Company, threatened, judicial,
administrative or arbitral action, claim, suit, proceeding or investigation
which might affect the validity or enforceability of this Agreement or which
involves the Company and which if adversely determined, could reasonably be
expected to have a material adverse effect on the Company.

                  (d) Except as disclosed in Schedule 5(d) hereto, to the actual
knowledge of the Company, no consent or approval of, or exemption by, or filing
with, any party or governmental or public body or authority is required in
connection with the execution, delivery and performance under this Agreement or
the taking of any action contemplated hereunder.

                  (e) The Company has been duly organized and is validly
existing as a corporation in good standing under the laws of the jurisdiction of
its incorporation.

                  (f) The execution, delivery and performance of this Agreement
by the Company, and the consummation of the transactions contemplated hereby,
will not (i) violate any provision of the Company's Certificate of Incorporation

                                       3

<PAGE>

or By-laws, (ii) violate, conflict with or result in the breach of any of the
terms of, result in a material modification of the effect of, otherwise, give
any other contracting party the right to terminate, or constitute (or with
notice or lapse of time or both constitute) a default under, any contract or
other agreement to which the Company is a party or by or to which the Company or
any of the Company's assets or properties may be bound or subject, (iii) violate
any order, judgment, injunction, award or decree of any court, arbitrator or
governmental or regulatory body by which the Company, or the assets or
properties of the Company are bound, (iv) to the Company's actual knowledge,
violate any statute, law or regulation.

         6. REPRESENTATIONS AND WARRANTIES OF THE INVESTOR. The Investor hereby
represents and warrants to the Company that:

                  (a) The Investor has the corporate power and authority to
enter into this Agreement and to perform its obligations hereunder. The
execution and delivery by the Investor of this Agreement, and the consummation
by the Investor of the transactions contemplated hereby, have been duly
authorized by all necessary corporate action on the part of the Investor. This
Agreement has been duly executed and delivered by the Investor and constitutes
valid and binding obligations of the Investor, enforceable against it in
accordance with its terms, subject to the effects of any applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors'
rights generally and to the application of equitable principles in any
proceeding (legal or equitable).

                  (b) The execution, delivery and performance by the Investor of
this Agreement, and the consummation of the transactions contemplated hereby, do

                                       4

<PAGE>

not and will not breach or constitute a default under any applicable law or
regulation or of any agreement, judgment, order, decree or other instrument
binding on the Investor.

                  (c) The Investor is a sophisticated investor (as described in
Rule 506(b)(2)(ii) of Regulation D) and an accredited investor (as defined in
Rule 501 of Regulation D), and the Investor has such experience in business and
financial matters that it is capable of evaluating the merits and risks of an
investment in the Preferred Stock. The Investor acknowledges that an investment
in the Preferred Stock, is speculative and involves a high degree of risk.

                  (d) Investor has received all documents, records, books and
other information pertaining to Investor's investment in the Company that have
been requested by Investor.

                  (e) At no time was Investor presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement or any
other form of general solicitation or advertising.

                  (f) Except as specifically set forth herein, Investor makes no
representations or warranties any other matter.

                  (g) The Investor has taken no action which would give rise to
any claim by any person for brokerage commissions, finder's fees or similar
payments relating to this Agreement or the transaction contemplated hereby.

                  (h) The Investor is the owner of good and marketable title to
the Securities, free and clear of all liens, pledges and encumbrances.

         7.       GOVERNING LAW; MISCELLANEOUS

                  (a) Governing Law; Jurisdiction. This Agreement shall be
deemed to be made in and in all respects shall be interpreted, construed and
governed by and in accordance with New York law without regard to the conflict

                                       5

<PAGE>

of law principles thereof, except that matters relating to the corporate
governance of the Company shall be governed by Delaware law. The parties hereby
irrevocably and unconditionally consent to submit to the exclusive jurisdiction
of the courts of the State of New York and of the United States of America
located in the Borough of Manhattan (the "New York Courts") for any litigation
arising out of or relating to this Agreement and the transactions contemplated
by this Agreement (and agree not to commence any litigation relating thereto
except in such New York Courts), waive any objection to the laying of venue of
any such litigation in the New York Courts and agree not to plead or claim in
any New York Court that such litigation brought therein has been brought in an
inconvenient forum. Each party acknowledges and agrees that any controversy
which may arise under this Agreement is likely to involve complicated and
difficult issues, and therefore each party hereby irrevocably and
unconditionally waives any right such party may have to a trial by jury in
respect of any litigation directly or indirectly arising out of or relating to
this Agreement, or the transactions contemplated by this Agreement.

                  (b) Counterparts. This Agreement may be executed in two or
more counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and
delivered to the other parties.

                  (c) Headings. The headings of this Agreement are for
convenience of reference and shall not form part of, or affect the
interpretation of, this Agreement.

                  (d) Severability. If any provision of this Agreement shall be
invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement or the validity or enforceability of this Agreement
in any other jurisdiction.

                                       6

<PAGE>

                  (e) Entire Agreement; Amendments. This Agreement and the
instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company nor the Investor
make any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived other than by an
instrument in writing signed by the party to be charged with enforcement and no
provision of this Agreement may be amended other than by an instrument in
writing signed by the Company and the Investor.

                  (f) Notices. Any notices required or permitted to be given
under the terms of this Agreement shall be sent by certified or registered mail
(return receipt requested) or delivered personally or by courier, overnight
delivery service or by confirmed telecopy, and shall be effective five days
after being placed in the mail, if mailed, or upon receipt or refusal of
receipt, if delivered personally or by courier, overnight delivery service or
confirmed telecopy, in each case addressed to a party. The addresses for such
communications shall be:

         If to the Company:
                                    Michael Sheppard
                                    HCOM Communications Inc.
                                    3495 Piedmont Road
                                    Building 12, Suite 110
                                    Atlanta, GA 30305

         with copy to:

                                    Foley Hoag LLP
                                    155 Seaport Boulevard
                                    Boston, MA 02210
                                    Attention: David A. Broadwin, Esq.
                                    Telephone: (617) 832-1000
                                    Fax: (617) 832-7000

                                       7

<PAGE>

         If to the Investor:
                                    c/o Lion Corporate Services
                                    Cumberland House
                                    27 Cumberland Street
                                    PO Box N-10818
                                    Nassau, New Providence
                                    Bahamas

         with a copy to:

         Each party shall provide notice to the other parties of any change in
address.

                  (g) Successors and Assigns. This Agreement shall be binding
upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company, nor the Investor shall assign this Agreement or any rights
or obligations hereunder without the prior written consent of the other.

         8. FURTHER ASSURANCES. Each party shall do and perform or cause to be
done and perform, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.

         9. CONDITIONS TO THE INVESTOR'S OBLIGATION TO EXCHANGE. The obligation
of the Investor to deliver the certificate(s) representing the Securities to
HCOM on the Closing Date is subject to the satisfaction, at or before the

                                       8

<PAGE>

Closing Date, of each of the following conditions thereto, provided that these
conditions are for the Investor's sole benefit and may be waived by the Investor
at any time in its sole discretion:

                  (a) HCOM shall have executed this Agreement and delivered the
same to the Investor.

                  (b) The representations and warranties of HCOM shall be true
and correct in all material respects as of the date when made and as of the
Closing Date as though made at that time (except for representations and
warranties that speak as of a specific date), and HCOM shall have performed,
satisfied and complied in all material respects with the covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied
with by HCOM on or prior to the Closing Date.

                  (c) HCOM shall have delivered to the Investor the duly
executed Preferred Stock in accordance with the terms herein.

                  (d) No litigation, statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction
or any self-regulatory organization having authority over the matters
contemplated hereby which prohibits the consummation of any of the transactions
contemplated by this Agreement.

         10. CONDITIONS TO HCOM's OBLIGATION TO EXCHANGE The obligation of HCOM
hereunder to deliver the Preferred Stock on the Closing Date is subject to the
satisfaction, at or before the Closing Date, of each of the following
conditions, provided that these conditions are for HCOM's sole benefit and may
be waived by HCOM at any time in its sole discretion.

                                       9

<PAGE>

                  (a) The Investor shall have executed this Agreement and
delivered same to HCOM.

                  (b) The Investor shall have delivered to HCOM the
certificates, duly endorsed for transfer, representing the Securities in
accordance with the terms herein.

                  (c) The representations and warranties of the Investor shall
be true and correct in all material respects as of the date when made and as of
the Closing Date as though made at such time (except for representations and
warranties that speak as of a specific date) and the Investor shall have
performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied
or complied with by the Investor on or prior to the Closing Date.

                  (d) No litigation, statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction
or any self-regulatory organization having authority over the matters
contemplated hereby which prohibits the consummation of any of the transactions
contemplated by this Agreement.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       10
<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first written above.

                                            HOMECOM COMMUNICATIONS, INC.

                                            By: ________________________________
                                            Name:
                                            Title:

                                            BRITTANY CAPITAL MANAGEMENT LTD.

                                            By: ________________________________
                                            Name: ______________________________
                                            Title: _____________________________

                                       11
<PAGE>

                                     ANNEX I

                             Form of Preferred Stock

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}]]